iShares US Pharmaceuticals ETF
IHE
IHE
139 hedge funds and large institutions have $326M invested in iShares US Pharmaceuticals ETF in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
Holders
139
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$13.1M | |
| 2 | +$6.45M | |
| 3 | +$2.21M | |
| 4 |
GC
Grimes & Company
Westborough,
Massachusetts
|
+$1.47M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.29M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$1.9M | |
| 3 | -$1.89M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.35M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.26M |
